Although initially described as a specific Importin-β inhibitor, Ive was recently demonstrated to induce DNA damage and cellular toxicity in multiple myeloma cells, which may indirectly contribute to affect the trafficking of Cx43 to the nucleus [33,57]. This evidence concerns the gene GJA1 and plasma cell myeloma.